Skip to main content
logo
Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
53.29
+0.22 (0.41%)
At close: Nov 6, 2026, 4:00 PM EST
52.49
-0.80 (-1.50%)
After-hours: Nov 6, 2026, 7:30 PM EST

Pulse Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.490.35--0.71.42
Revenue Growth
1637.21%----50.63%-
Gross Profit
0.4-0.19---11.24-0.55
Operating Income
-87.57-76.94-56.26-43.57-58.06-63.01
Net Income
-83.72-72.78-53.59-42.21-58.51-63.66
Earnings Per Share
-1.21-1.08-0.92-0.85-1.72-2.28
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
189.1980.74118.0444.3761.1428.61
Total Debt
6.367.538.99.1475.9611.25
Net Cash (Debt)
182.8373.21109.1435.22-14.8217.36
Net Cash Growth
109.37%-32.93%209.87%--90.42%
Net Cash Per Share
2.641.091.870.71-0.440.62

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-63.33-54.12-36.34-33.04-47.01-54.1
Capital Expenditures
-0.37-0.32-0.13-0.12-0.4-0.44
Free Cash Flow
-63.7-54.44-36.47-33.16-47.41-54.53
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
26.77%-54.00%----38.79%
Operating Margin
-5861.24%-21982.57%---8293.86%-4443.87%
Pretax Margin
-5603.88%-20794.57%---8357.86%-4489.42%
Profit Margin
-5603.88%-20794.57%---8357.86%-4489.42%
FCF Margin
-4263.86%-15553.43%---6773.43%-3845.84%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2623.442658.43--147.32309.48